Propanc Biopharma Analysis
Propanc Biopharma is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Propanc Biopharma pink sheet analysis is to determine its intrinsic value, which is an estimate of what Propanc Biopharma is worth, separate from its market price. There are two main types of Propanc Biopharma's stock analysis: fundamental analysis and technical analysis.
The Propanc Biopharma pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Propanc Biopharma's ongoing operational relationships across important fundamental and technical indicators.
Propanc |
Propanc Pink Sheet Analysis Notes
The company recorded a loss per share of 16.63. Propanc Biopharma had not issued any dividends in recent years. The entity had 1-1000 split on the 19th of November 2020. Propanc Biopharma, Inc., a development-stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Propanc Biopharma, Inc. was founded in 2007 and is based in Camberwell, Australia. Propanc Biopharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.The quote for Propanc Biopharma is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Propanc Biopharma contact the company at 61 3 9882 0780 or learn more at http://www.propanc.com.Propanc Biopharma Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Propanc Biopharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Propanc Biopharma or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Propanc Biopharma is not yet fully synchronised with the market data | |
| Propanc Biopharma has some characteristics of a very speculative penny stock | |
| Propanc Biopharma has a very high chance of going through financial distress in the upcoming years | |
| Propanc Biopharma has accumulated 1.1 M in total debt. Propanc Biopharma has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Propanc Biopharma until it has trouble settling it off, either with new capital or with free cash flow. So, Propanc Biopharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Propanc Biopharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Propanc to invest in growth at high rates of return. When we think about Propanc Biopharma's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.67 M). | |
| Propanc Biopharma has accumulated about 51.22 K in cash with (1.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07. |
Propanc Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 259.19 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Propanc Biopharma's market, we take the total number of its shares issued and multiply it by Propanc Biopharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Propanc Biopharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Propanc Pink Sheet
If you are still planning to invest in Propanc Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Propanc Biopharma's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |